| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |